Chemotherapy helps only 10% of metastatic melanoma patients, usually for just a few months.

FORBES: Magazine Article

In March, the Food and Drug Administration cleared Yervoy, the first drug to extend the survival of patients with metastatic melanoma, by several months.

FORBES: The Best Big Drug Company Of 2011

Phase 2 testing of elesclomol resulted in surprising data indicating that the compound might be an effective treatment for metastatic melanoma, a form of skin cancer that was notoriously resistant to treatment.

NEWYORKER: The Treatment